Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Roche

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Clinics and Research in Hepatology and Gastroenterology|April 2, 2014
Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study)Jérôme Dumortier, Ephrem Salamé, Bruno Roche, et al.
World Journal of Gastroenterology|May 17, 2016
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrenceAlice Tung Wan Song, Rodolphe Sobesky, Carmen Vinaixa, et al.
Transplantation|March 30, 2016
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter StudyPaolo De Simone, Renato Romagnoli, Francesco Tandoi, et al.
Plos One|September 23, 2015
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Audrey Coilly, Jérôme Dumortier, Danielle Botta-Fridlund, et al.
Clinics and Research in Hepatology and Gastroenterology|August 25, 2016
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)Hélène Fontaine, Marianne Maynard, Cécile Bouix, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2026
Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient SurvivalIsaure Bienvenue, Olivier Roux, Audrey Coilly, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitisJean-Baptiste Nousbaum, Jean-François Cadranel, Pierre Nahon, et al.
Journal of Medical Virology|October 27, 2009
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapyFlorence Legrand-Abravanel, Philippe Colson, Hélène Leguillou-Guillemette, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Clinics and Research in Hepatology and Gastroenterology|April 2, 2014
Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: a French experience on 250 patients over 15 years (the Orfèvre study)Jérôme Dumortier, Ephrem Salamé, Bruno Roche, et al.
World Journal of Gastroenterology|May 17, 2016
Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrenceAlice Tung Wan Song, Rodolphe Sobesky, Carmen Vinaixa, et al.
Transplantation|March 30, 2016
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter StudyPaolo De Simone, Renato Romagnoli, Francesco Tandoi, et al.
Plos One|September 23, 2015
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Audrey Coilly, Jérôme Dumortier, Danielle Botta-Fridlund, et al.
Clinics and Research in Hepatology and Gastroenterology|August 25, 2016
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)Hélène Fontaine, Marianne Maynard, Cécile Bouix, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 11, 2026
Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient SurvivalIsaure Bienvenue, Olivier Roux, Audrey Coilly, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitisJean-Baptiste Nousbaum, Jean-François Cadranel, Pierre Nahon, et al.
Journal of Medical Virology|October 27, 2009
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapyFlorence Legrand-Abravanel, Philippe Colson, Hélène Leguillou-Guillemette, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Pageof 11